‘Intelligence report’ on Siddaramaiah’s assembly seat fake, clarifies CMO

News Network
April 7, 2018

Bengaluru, Apr 7: The Chief Minister’s Office (CMO) on Saturday clarified that a so called Intelligence report that is doing rounds on social media, stating that Chamundeshwari Assembly constituency not safe for Chief Minister Siddaramaiah, was a fake report.

The Intelligence DIG has been asked to conduct a probe into the fake report, the CMO stated in a press release.

"The Intelligence department has not given any such report. The report is false and fabricated. The ADGP post in the Intelligence department is lying vacant. Moreover, the Intelligence reports are usually in Kannada, not English," the CMO explained.

HDK endorses report

Meanwhile, JD(S) leader H D Kumaraswamy has endorsed the alleged intelligent report. "The Intelligence report has cautioned Siddaramaiah against contesting from Chamundeshwari Assembly constituency. It says that the JD(S) leaders, including the sitting MLA from the party G T Devegowda, are mobilising Vokkaliga votes and that contesting from Chamundeshwari is not a viable option for CM," Kumaraswamy said

"The report also recommended the CM alternative options. It suggested that Varuna (Mysuru), Basavakalyan (Bidar), Gangavati (Koppal) and Shantinagar (Bengaluru) constituencies are safe for the chief minister," the JD(S) leader said.

Comments

Wellwisher
 - 
Saturday, 7 Apr 2018

This criminal deh drohi rss will do any thing for the seat and to ignite communal tension. They will ready to revolt against their own parents. They will ready to refuse theor own father. Then what about our state CM. They will do any thing against our state ministers.

Danish
 - 
Saturday, 7 Apr 2018

Cant frighten siddaramaiah with this kind of dummy snakes

Kumar
 - 
Saturday, 7 Apr 2018

BJP will do all gimmicks to defeat cong

Ganesh
 - 
Saturday, 7 Apr 2018

That "intelligence report" may be done by JD(S) or BJP cyber wing

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 23,2020

Bengaluru, Jun 23: Karnataka Medical Education Minister K Sudhakar's wife and daughter have tested positive for COVID-19, a day after his father was confirmed to have been infected with the virus.

"Test results of our family members have come. Unfortunately, my wife and daughter have tested positive for #Covid19 and are undergoing treatment," the minister tweeted on Tuesday.

He said he and his two sons have tested negative.

Sudhakar's father P N Keshava Reddy tested positive for coronavirus on Monday. He was admitted to the hospital with a cough and fever.

Earlier, the domestic help of the minister had tested coronavirus positive and was admitted to a hospital.

In April, Sudhakar was quarantined along with three other ministers for coming in contact with a journalist who was coronavirus positive.

Karnataka reported 249 new COVID-19 cases and five deaths on Monday taking the total number of cases in the state to 9,399 and the death toll to 142.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

Bengaluru, June 29: The Karnataka government on Monday issued guidelines to conduct online classes for all students of ICSE, CBSE and SSLC under the directions of the High Court.

According to the guidelines, for the kindergarten students, online classes can be held 30 minutes a week and students in classes 1-5 will have online classes for 30-45 minutes divided into two periods for three alternate days every week.

For students in classes 6-8, the online classes will be for 30-45 minutes divided into two periods for five days every week while students in classes 9 and 10 can have the virtual classes for 30-45 minutes divided into four periods for five days a week.

Earlier, the state government barred online classes for the kids from LKG to class 5.

Minister for primary and secondary education S Suresh Kumar had said that online classes cannot be held for the kids from LKG to class V.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.